Search results for "Hepatocellular carcinoma"
Spotlight on cirrhosis
Patients with cirrhosis were the focus of several recent studies, which reviewed the evidence behind nutritional assessment, calculated the cost-effectiveness of hepatocellular carcinoma screening, and estimated the prevalence of nonalcoholic steatohepatitis-associated cirrhosis.
https://gastroenterology.acponline.org/archives/2017/02/24/5.htm
24 Feb 2017
High HCV cure rate seen with FDA-approved direct-acting antiviral regimens
Six of the direct-acting antiviral (DAA) regimens yielded sustained virologic response rates above 95% in patients who had hepatitis C virus (HCV) genotype 1 without cirrhosis, including those with HIV co-infection.
https://gastroenterology.acponline.org/archives/2017/03/24/7.htm
24 Mar 2017
Regorafenib now FDA-approved to treat hepatocellular carcinoma
Approved use of the drug has been expanded to include treatment of patients with hepatocellular carcinoma who have been treated with sorafenib.
https://gastroenterology.acponline.org/archives/2017/05/26/7.htm
26 May 2017
Spotlight on statin therapy
Studies published in May found a potential benefit of statin therapy for three different conditions.
https://gastroenterology.acponline.org/archives/2017/05/26/5.htm
26 May 2017
Review: In chronic hepatitis C virus infection, oral direct-acting antivirals have high sustained virologic response
A commentary in ACP Journal Club noted that while screening and treating all patients with chronic hepatitis C virus (HCV) would be cost-effective and probably cost-saving, some payers are still resistant.
https://gastroenterology.acponline.org/archives/2017/07/28/11.htm
28 Jul 2017
Spotlight on hepatocellular cancer
One recent study assessed occurrence of hepatocellular carcinoma in patients with hepatitis C-associated cirrhosis, while another looked at the effect of hepatobiliary cancer surveillance on outcomes in patients with primary sclerosing cholangitis.
https://gastroenterology.acponline.org/archives/2018/04/27/6.htm
27 Apr 2018
Spotlight on mortality trends in liver disease
One study looked at 10-year U.S. mortality trends related to chronic liver diseases, while another assessed mortality from cirrhosis and liver cancer in the U.S. from 1999 to 2016.
https://gastroenterology.acponline.org/archives/2018/07/27/5.htm
27 Jul 2018
Statins associated with reduced mortality risk in hepatocellular carcinoma
Inverse associations between postdiagnosis statin use and cancer-specific and all-cause mortality were consistent for low- and high-dose statins and for a range of time periods after cancer diagnosis.
https://gastroenterology.acponline.org/archives/2019/01/25/2.htm
25 Jan 2019
More liver transplants occurring in patients with alcohol-associated liver disease
The increase from 2002 to 2016 can partly be explained by reductions in hepatitis C-related transplants but may also indicate changing perspectives on abstinence requirements, study authors said.
https://gastroenterology.acponline.org/archives/2019/01/25/4.htm
25 Jan 2019
Spotlight on direct-acting antivirals
Studies of contemporary populations with hepatitis C virus infection demonstrated that treatment with direct-acting antiviral therapies was linked to improvement in several long-term clinical outcomes.
https://gastroenterology.acponline.org/archives/2019/02/22/5.htm
22 Feb 2019